Safety and efficacy of Cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP) / Procopio, G; Prisciandaro, M; Iacovelli, R; Mancini, M; Fornarini, G; Facchini, G; Carteni, G; Napolitano, M; Sternberg, Cn; Caserta, C; Bregni, M; Massari, F; Buti, S; Biasco, E; De Giorgi, U; Zustovich, F; Ratta, R; Ortega, C; Tortora, G; Verzoni, E. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:Supplement 5(2017), pp. 319-320.

Safety and efficacy of Cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP)

Buti S;
2017

Safety and efficacy of Cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP) / Procopio, G; Prisciandaro, M; Iacovelli, R; Mancini, M; Fornarini, G; Facchini, G; Carteni, G; Napolitano, M; Sternberg, Cn; Caserta, C; Bregni, M; Massari, F; Buti, S; Biasco, E; De Giorgi, U; Zustovich, F; Ratta, R; Ortega, C; Tortora, G; Verzoni, E. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:Supplement 5(2017), pp. 319-320.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2906896
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact